Is Swedish Orphan Biovitrum AB (publ) Stock Halal?
Shariah Compliance Analysis of SOBI.ST Stock
Sweden Health Care Large Cap
Yes. As of September 2026, Swedish Orphan Biovitrum AB (publ) (SOBI.ST) is classified as HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Swedish Orphan Biovitrum AB (publ) passes Musaffa's business and financial screening criteria.
Swedish Orphan Biovitrum AB engages in the research, development, manufacture, and sale of pharmaceuticals. The company is headquartered in Stockholm, Stockholm and currently employs 1,969 full-time employees. The company went IPO on 2006-09-15. The firm develops, manufactures and sells medications within hemophilia, autoimmune diseases, metabolic diseases and cancer supportive care. The Company’s product portfolio is divided into three business segments: the Core Products segment offers pharmaceuticals within Inflammation area, and Genetics and metabolic therapeutic area; the Partner Products segment offers about 40 pharmaceuticals within hematology, oncology and emergency medicines, and the ReFacto Manufacturing segment. The firm has subsidiaries in Sweden, Denmark, Finland, Norway, United Kingdom and France, among others.
Swedish Orphan Biovitrum AB (publ) SOBI.ST
Last Updated: Sep 14, 12:00 AM·OMXS
SOBI.ST Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, Swedish Orphan Biovitrum AB (publ) is classified as halal.